Pérez-Bouza A - Search Results

1

Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue.

Andres RH, Ducray AD, Huber AW, Pérez-Bouza A, Krebs SH, Schlattner U, Seiler RW, Wallimann T, Widmer HR. Andres RH, et al. J Neurochem. 2005 Oct;95(1):33-45. doi: 10.1111/j.1471-4159.2005.03337.x. Epub 2005 Jul 25. J Neurochem. 2005. PMID: 16045451 Free article.

2

Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.

Andres RH, Huber AW, Schlattner U, Pérez-Bouza A, Krebs SH, Seiler RW, Wallimann T, Widmer HR. Andres RH, et al. Neuroscience. 2005;133(3):701-13. doi: 10.1016/j.neuroscience.2005.03.004. Neuroscience. 2005. PMID: 15890457

3

Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons.

Schaller B, Andres RH, Huber AW, Meyer M, Pérez-Bouza A, Ducray AD, Seiler RW, Widmer HR. Schaller B, et al. Brain Res. 2005 Mar 2;1036(1-2):163-72. doi: 10.1016/j.brainres.2004.12.054. Brain Res. 2005. PMID: 15725414

4

Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system.

Andres RH, Ducray AD, Pérez-Bouza A, Schlattner U, Huber AW, Krebs SH, Seiler RW, Wallimann T, Widmer HR. Andres RH, et al. Cell Transplant. 2005;14(8):537-50. doi: 10.3727/000000005783982756. Cell Transplant. 2005. PMID: 16355565 Free article.

5

Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson's Disease.

Perez-Bouza A, Di Santo S, Seiler S, Meyer M, Andereggen L, Huber A, Guzman R, Widmer HR. Perez-Bouza A, et al. Cell Transplant. 2017 Sep;26(9):1572-1581. doi: 10.1177/0963689717721202. Cell Transplant. 2017. PMID: 29113462 Free PMC article.

6

Long-term survival and bipotent terminal differentiation of human mesenchymal stem cells (hMSC) in combination with a commercially available three-dimensional collagen scaffold.

Neuss S, Stainforth R, Salber J, Schenck P, Bovi M, Knüchel R, Perez-Bouza A. Neuss S, et al. Cell Transplant. 2008;17(8):977-86. doi: 10.3727/096368908786576462. Cell Transplant. 2008. PMID: 19069639 Free article.

7

[Mesenchymal stem cells for bone tissue engineering].

Schneider RK, Neuss S, Knüchel R, Perez-Bouza A. Schneider RK, et al. Pathologe. 2010 Oct;31 Suppl 2:138-46. doi: 10.1007/s00292-010-1329-7. Pathologe. 2010. PMID: 20711587 German.

8

Three-dimensional epidermis-like growth of human mesenchymal stem cells on dermal equivalents: contribution to tissue organization by adaptation of myofibroblastic phenotype and function.

Schneider RK, Neuss S, Stainforth R, Laddach N, Bovi M, Knuechel R, Perez-Bouza A. Schneider RK, et al. Differentiation. 2008 Feb;76(2):156-67. doi: 10.1111/j.1432-0436.2007.00204.x. Epub 2007 Jul 18. Differentiation. 2008. PMID: 17634073

9

The use of a shape-memory poly(epsilon-caprolactone)dimethacrylate network as a tissue engineering scaffold.

Neuss S, Blomenkamp I, Stainforth R, Boltersdorf D, Jansen M, Butz N, Perez-Bouza A, Knüchel R. Neuss S, et al. Biomaterials. 2009 Mar;30(9):1697-705. doi: 10.1016/j.biomaterials.2008.12.027. Epub 2009 Jan 1. Biomaterials. 2009. PMID: 19121539

10

Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents.

Schneider RK, Püllen A, Kramann R, Bornemann J, Knüchel R, Neuss S, Perez-Bouza A. Schneider RK, et al. Differentiation. 2010 Mar;79(3):182-93. doi: 10.1016/j.diff.2010.01.005. Epub 2010 Feb 11. Differentiation. 2010. PMID: 20153102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters